Prolytix is a leading analytical CRO with 30+ years of protein chemistry experience in plasma-based protein therapies, monoclonal and polyclonal antibodies, recombinant proteins, cell and gene therapies, and vaccines and viral vectors, from discovery through commercial GMP release and stability. Prolytix also develops custom collection tubes, vials, other devices for nonclinical and clinical research and manufactures standard and custom plasma-derived coagulation proteins, antibodies, and factor deficient plasma research reagents.